ECTRIMS 2019: First international data of Mesenchymal stem cells therapy

Per Soelberg | ECTRIMS 2019 | SYYSKUU 13, 2019

Asiantuntija: Per Soelberg

In this MEDtalk Per Soelberg Sørensen present data from a international, multi-center where patients with active relapsing remitting, secondary progressive (SP) or primary progressive MS was treatet with Mesenchymal stem cells.